A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

NCT05565742 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Lipoprotein Disorder

Interventions

DRUG: LY3819469
DRUG: Placebo

Sponsor

Eli Lilly and Company